Yersinia pestis Fraction 1 capsular antigen (F1 antigen) (F1 antigen)

The Yersinia pestis Fraction 1 (F1) capsular antigen is a major surface protein and a critical virulence factor of the bacterium responsible for the plague. Encoded by the caf1 gene on the pFra plasmid, F1 assembles into a large, gel-like capsule that surrounds the bacterium when it is grown at 37°C, the body temperature of mammalian hosts (UniProt: P0C1M3). Its primary biological function is to inhibit phagocytosis by host immune cells, such as macrophages and neutrophils, thereby allowing the pathogen to proliferate in the lymphatic system and bloodstream (PubMed: 15273338). Because of its high immunogenicity and surface exposure, the F1 antigen is the central component of most subunit plague vaccines, often paired with the V antigen (rF1-V) to provide synergistic protection (NIH: Plague Vaccine Development). In addition to its role in vaccine development, the F1 antigen serves as a primary diagnostic biomarker for the rapid detection of plague in clinical and environmental samples (CDC: Plague Diagnosis). However, the existence of naturally occurring or engineered F1-negative strains poses a significant challenge to F1-based countermeasures, as these strains remain virulent but can evade F1-targeted immunity and diagnostics (PubMed: 11118161).

Other names

Caf1Fraction 1 proteinF1 proteinCapsular antigen F1Yersinia pestis Caf1 protein

Vaccines and therapeutics targeting the F1 antigen work by inducing or providing high-affinity antibodies that bind to the bacterial capsule. This binding neutralizes the antiphagocytic effect of the F1 protein and promotes opsonization, allowing host phagocytes to recognize, engulf, and destroy the Yersinia pestis bacteria (PubMed: 15273338).